Myeloid/lymphoid neoplasms with eosinophilia/ basophilia and ETV6-ABL1 fusion: cell-of-origin and response to tyrosine kinase inhibition

類似資料

• Incidental changes in hemoglobin levels in patients with myelofibrosis receiving treatment with sodium-glucose co-transporter-2 inhibitors
  著者:: Fnu Aperna, 等
  出版事項: (2024-11-01)
• Selinexor for myelofibrosis or a drug in search of a disease?
  著者:: Naseema Gangat, 等
  出版事項: (2026-07-01)
• Momelotinib in JAK2 inhibitor-naïve myelofibrosis: pros and cons
  著者:: Naseema Gangat, 等
  出版事項: (2025-05-01)
• Triple-negative primary myelofibrosis: a comparative analysis of phenotype, genotype, and outcome
  著者:: Yassin A. Bashir, 等
  出版事項: (2026-01-01)
• Myeloproliferative neoplasms with clinically relevant paroxysmal nocturnal hemoglobinuria: clinical correlations and outcomes
  著者:: Priyansh Faldu, 等
  出版事項: (2025-11-01)